Congruence Therapeutics
Nathalia Azevedo Portilho, PhD, is a Senior Scientist at Congruence Therapeutics with extensive experience in molecular biology, stem cells, and genetic engineering. With a PhD in Cellular and Molecular Biology, Nathalia has conducted research at various prestigious institutions including McGill University, UTHealth, Fiocruz, and Queen's University. As a dedicated researcher, Nathalia has contributed significantly to the understanding of stem cell differentiation and blood cell development. Throughout their career, Nathalia has demonstrated exceptional project management skills and a strong passion for advancing scientific knowledge.
Congruence Therapeutics
Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.